Sharad goyal, md

SHARAD GOYAL, MD
Masters of Science in Clinical Investigation, University of Virginia
Doctorate of Medicine, University of Virginia
Bachelors of Arts in Biology, University of Virginia
Radiation Oncology, Rutgers/Robert Wood Johnson Medical School (RWJMS)
Radiation Oncology, Howard University Hospital
Internal Medicine, University Hospitals of Cleveland (CWRU)
Assistant Professor, Rutgers/Robert Wood Johnson Medical School (RWJMS)
Assistant Professor, Rutgers/The Cancer Institute of New Jersey
Faculty, Graduate School of Biomedical Science (RWJMS) Associate Member, MS in Clinical & Translational Science Program Assistant Professor, Rutgers/New Jersey Medical School (NJMS) Instructor, Rutgers/Robert Wood Johnson Medical School (RWJMS)
Instructor, Rutgers/The Cancer Institute of New Jersey
T32 Research Fellowship (NCI Funded), The Cancer Institute of New Jersey
Chief Resident, Dept of Radiation Oncology, Rutgers/RWJMS
Gamma Knife Perfexion Training Course, Pittsburgh, PA Board Certification, American Board of Radiology
New Jersey State Medical Board (#25MA08439100) Grand Rounds, Loyola University, Department of Radiation Oncology Author, Principles and Practice of Radiation Oncology, Ch 56 Moderator, American Brachytherapy Society, New Orleans, LA RSNA Clinical Trials Methodology Workshop, Scottsdale, AZ RSNA Discussant, BOOST session, Chicago, IL RSNA Keynote Speaker, Breast session, Chicago, IL 2013 ABS Breast Scientific Session Abstract Reviewer EBC Radio Show – South Asians & Cancer Incidence CAPSTONE Mentor, MS in Clinical & Translational Science Moderator, Sino-American Network of Therapeutic Radiation Oncology Moderator, Addressing Health Disparities in the South Asian Population Faculty, Contouring Learning Lab, American Radium Society Annual Meeting Moderator, Breast Session, American Radium Society Annual Meeting Proton Therapy Co-Operative Group (PTCOG) Travel Fellowship 2008 American Brachytherapy Society (ABS) HDR Brachytherapy Fellowship AACR/ASCO Methods in Clinical Cancer Research Workshop (Vail, Co) Graduated from a 4 year Joint MD-MS in Clinical Investigation program Dean’s List 5/7 Semesters at the University of Virginia ASTRO Constitution/Bylaws Committee of the ASTRO Board of Directors Annual Meeting Education Committee (ASTRO) Breast Cancer Appropriateness Criteria Panel Member (ACR) Constitution/Bylaws Committee of the Standings Committee (ASTRO) Education Sessions Subcommittee of the Education Council (ASTRO) Leadership Development Committee Working Group (ASCO) Professional Development Committee (ASCO) Cancer Curriculum Advisory Committee (CINJ) Curriculum Evaluation Task Force (UMDNJ/NJMS) Breast Cancer Services Leadership Team (RWJ University Hospital) Curriculum Working Group - Cancer: Bench to Bedside (UMDNJ/RWJMS) Practice Quality Improvement Team (RWJ University Hospital) Radiological Society of North America (RSNA) American Society of Clinical Oncology (ASCO) American Society for Therapeutic Radiology and Oncology (ASTRO) 1. Co-Principal Investigator. U01. Stereotactic Hypofractionated Accelerated Radiation and
Prostatectomy in Patients with Elevated Risk (The SHARPER Trial – A Phase One Study). 2014-2017
($3,750,000 - SUBMITTED).
2. Principal Investigator. American Heart Association Mentored Clinical and Population Research Award.
Radiation from Interventional Cardiovascular Procedures and Risk of Breast Cancer. SUBMITTED.
2013-2015 ($275,000).
3. Principal Investigator. RSNA 2011 Education Scholar Grant. COntouring in Radiation oncology Education
(CORE). 2011-2013 ($150,000).
4. Principal Investigator. UMDNJ Foundation Grant. Feasibility of APBI for early-stage breast cancer
patients using fiducial markers. 2009-2011 ($25,000).
5. Co-Principal Investigator. American College of Radiology. Development of a Quality Radiation
Oncology Practice Initiative. 2008-2010 ($18,000).
6. Training Grant. NIH T-32 Training Program in Cancer Biology. Molecular mechanisms of radiation
resistance. 2008-2009 ($84,580).
1. Principal Investigator. CINJ 041305. Women With Breast Cancer Treated With Post-Mastectomy
2. Principal Investigator. CINJ XXXXXX. A Phase I Dose per Fraction Escalation Trial of Radiotherapy in
Combination with Xeloda in Patients Necessitating Chest Wall Radiotherapy. Submitted to SRB. 3. Principal Investigator. CINJ 081005. Stereotactic Hypofractionated Accelerated Radiation and
Prostatectomy in Patients with Elevated Risk Prostate Cancer (The SHARPER Trial). IRB Approved. 4. Investigator. CINJ 040807 Safety and Feasibility of Accelerated, Hypofractionated Radiotherapy in
Women with Breast Cancer: A Phase II Trial. IRB Approved. 5. Investigator. CINJ 040902: Safety and Feasibility of Short-course, Accelerated, Hypo-fractionated APBI
in Older Women (≥ 50 years) with Early Stage Breast Cancer: A Phase II Trial. IRB Approved. 6. Principal Investigator. CINJ 040801 Feasibility of 3-D Conformal Accelerated Partial Breast Irradiation
(APBI) for Early Stage, Node Negative Breast Cancer Patients using Acculoc Fiducial Markers. Study
PEER-REVIEWED PUBLICATIONS
1. Goyal S, Daroui P, Kearney T, Kirstein L, Haffty BG. 3 year outcomes of a Novel Fractionation Scheme
in Accelerated Partial Breast Irradiation (APBI) Using 3-D Conformal Radiotherapy (3D-CRT). Accepted by Cancer Medicine.
2. Ferro A, Goyal S, Kim S, Wu H, Schiff DS, Pirmalata A, Haffty BG. Evaluation of Diabetic Patients with
Breast Cancer treated with Metformin during Adjuvant Radiotherapy. Accepted by the International 3. Goyal S, Daroui P, Kearney T, Kirstein L, Haffty BG. 3 year outcomes of a Novel Fractionation Scheme
in Accelerated Partial Breast Irradiation (APBI) Using 3-D Conformal Radiotherapy (3D-CRT). Accepted by Cancer Medicine.
4. Ferro A, Goyal S, Kim S, Wu H, Schiff DS, Pirmalata A, Haffty BG. Evaluation of Diabetic Patients with
Breast Cancer treated with Metformin during Adjuvant Radiotherapy. Accepted by the International 5. Pirmalata A, Ferro A, Yue NJ, Haffty BG, Goyal S. Optimization of Surgical Clip Placement for Breast-
Conservation Therapy. Accepted by Pract Radiat Oncol.
6. Khan AJ, Parikh RR, Neboori H, Goyal S, Haffty BG, Moran MS. The Relative Benefits of Tamoxifen in
Older Women with T1 Early-Stage Breast Cancer Treated with Breast-Conserving Surgery and Radiation Therapy. The Breast Journal. 2013 Jun 26. doi: 10.1111/tbj.12150.
7. Danish H, Goyal S, Taunk NK, Wu H, Moran MS, Haffty BG. Prognostic significance of Interferon
induced protein with tetratricopeptide repeats 1 (IFIT1) expression in early stage breast cancer patients treated with breast conserving surgery and radiation therapy. The Breast Journal. 2013 Mar
8. Yue NJ, Goyal S, Kim LH, Khan AJ, Haffty BG. Patterns of Intra-fractional Motion and Uncertainties of
Treatment Setup Reference Systems In Accelerated Partial Breast Irradiation for Right- and Left-sided Breast Cancer. Pract Radiat Oncol. 2013 Feb 4. E-pub.
9. Yue NJ, Haffty BG, Kearney T, Chen S, Haffty BG, Goyal S. Tracking the Dynamic Seroma Cavity using
Fiducial Markers in Patients Treated with 3-D Conformal Radiotherapy (3D-CRT) Accelerated Partial Breast Irradiation (APBI)). Med Phys. 2013 Feb;40(2):021717.
10. Goyal S, Shah S, Khan AJ, Danish H, Haffty BG. Evaluation of Acute Toxicity in Patients Treated With
Concurrent Pazopanib & Radiotherapy. IRSN Oncology. Epub 2012 Dec 6.
11. Shaikh T, Narra V, Goyal S, Ahlawat S, Kirstein L, Kearney TK, Haffty BG, Khan AJ. Type of Lumpectomy
Cavity Closure Does Not Affect Absolute Target Volume or Normal Tissue Dosimetry. Ann Surg Oncol.
12. Levinson LL, Yue NJ, Zhou J, Chen T, Goyal S. Determination of Optimal Fiducial Marker Across Image
Guided Radiation Therapy (IGRT) Modalities: Visibility and Artifact Analysis of Gold, Carbon, and Polymer Fiducial Markers. J Clin App Med Phys. 2012; 13(5): 3976.
13. Zhou J, Zhang S, Kims S, Jabbour SK, Goyal S, Haffty BG, Metaxasis D, Yue NJ. A Laplacian Surface
Deformation and Optimization based 3D Registration Algorithm for Image Guided Prostate Radiotherapy. IJMPCERO. 2012; 1(2): 40-49.
14. Nelson C, Bai H, Neboori H, Takita C, Wright J, Motwani S, Hobeika G, Haffty BG, Walker G, Goyal S,
Tavasolli F, Moran MS. Multi-Institutional Experience of Ductal Carcinoma In-Situ in African American versus White Patients Treated With Breast Conserving Surgery & Whole Breast Radiation Therapy. Int
J Radiat Oncol Biol Phys. 2012; June 5 (E-Pub).
15. Neboori H, Wu H, Yang Q, Goyal S, Schiff D, Moran MS, Moore D, Ganesan S, Haffty BG. Low p53
Binding Protein 1 (53BP1) Expression is Associated with Increased Local Recurrence in Breast Cancer Patients Treated with Breast Conserving Surgery and Radiation Therapy (BCS+RT). Int J Radiat Oncol
Biol Phys. 2012; April 18 (E-Pub).
16. Halyard MY, Wasif N, Harris ER, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Horst KC, Macdonald
SM, McDonald M, Moran MS, Haffty BG. Local Regional Recurrence (LR) and Salvage Surgery (ACR Appropriateness Criteria®). Am J Clin Oncol. 2012; 35(2):178-182.
17. Kim LH, Goyal S, Haffty BG, Taunk NK, Yue NJ. Using Respiratory Motion to Guide Planning Target
Volume Margins for External Beam Partial Breast Irradiation. Int J Radiat Oncol Biol Phys. 2012;
18. Khan AJ, Vicini FA, Beitsch PD, Keisch M, Goyal S, Quiet C, Keleher A, Garcia D, Snider H, Gittleman M,
Zannis V, Kuerer H, Whitacre E, Whitworth P, Lyden M, Fine R, Haffty BG . Local control, toxicity, and cosmesis in women 70 or older enrolled on the American Society of Breast Surgeons Mammosite RTS Registry Trial. Int J Radiat Oncol Biol Phys. 2012 Feb 21. (E-Pub).
19. Daroui P, Gabel M, Khan AJ, Haffty BG, Goyal S. Utilization of Breast Conserving Therapy in Stage 0, I,
II Breast Cancer Patients in New Jersey: An American College of Surgeons National Cancer Data Base (NCDB) Analysis. Am J Clin Oncol. 2012;35(2):130-5.
20. Khan AJ, Arthur D, Vicini FA, Beitsch PD, Kuerer H, Goyal S, Lyden M, Haffty BG. Six-Year Analysis of
Treatment Related Toxicities in Patients Treated With Accelerated Partial Breast Irradiation on the American Society of Breast Surgeons MammoSite® Breast Brachytherapy Registry Trial. Ann Surg
Oncol. 2011 Nov 23. (E-Pub).
21. Moran MS, Haffty BG, Harris ER, Arthur DW, Bailey L, Carey L, Goyal S, Halyard MY, Horst KC,
Macdonald SM. Conservative Surgery & Radiation – Ductal Carcinoma in Situ (ACR Appropriateness Criteria®). The Breast Journal. 2012; 18(1):8-15.
22. Vicini FA, Keisch M, Goyal S, Khan AJ, Beitsch PD, Lyden M, Shah C, Haffty BG. Factors Associated with
Optimal Long-Term Cosmetic Results in Patients Treated with Accelerated Partial Breast Irradiation (APBI) Using Balloon Based Brachytherapy. Int J Radiat Oncol Biol Phys. 2011 Nov 11. (E-pub).
23. Macdonald SM, Haffty BG, Harris ER, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Halyard MY,
Horst KC, Moran MS. Locally Advanced Breast Cancer (ACR Appropriateness Criteria®). The Breast
Journal. 2011; 17(6):579-585.
24. Bellon JR, Haffty BG, Harris ER, Arthur DW, Bailey L, Carey L, Goyal S, Halyard MY, Horst KC,
Macdonald SM, Moran MS. Conservative Surgery & Radiation – Stage I&II Breast Carcinoma (ACR Appropriateness Criteria®). The Breast Journal. 2011; 17(5):448-455.
25. Taunk NK, Goyal S, Wu H, Moran MS, Chen S, Haffty BG. DEAD box 1 (DDX1) Expression Predicts for
Local Control and Overall Survival in Early Stage, Node Negative Breast Cancer. Cancer. 2011;
26. Aburabia M, Roses RE, Kuerer HM, Fine R, Beitsch PD, Goyal S, Haffty BG, Lyden M, Vicini FA. Axillary
Failure in Patients Treated with MammoSite Accelerated Partial Breast Irradiation. Ann Surg Oncol.
27. Azu M, Goyal S, Patel U, Haffty BG, Kearney T. Has Placement of Surgical Clips in the Lumpectomy Bed
Fallen out of Favor? Ann Surg Oncol. 2011; 18(6):1529-32.
28. Taunk NK, Haffty BG, Chen S, Khan AJ, Nelson C, Pierce D, Goyal S. Comparison of Radiation-Induced
Fatigue Using 3 Radiotherapeutic Methods in Early Stage Breast Cancer Radiotherapy. Cancer. 2011;
29. Motwani S, Goyal S, Moran MS, Patel A, Haffty BG. Ductal Carcinoma in situ (DCIS) Treated with
Breast Conserving Surgery & Radiotherapy: Comparison with Eastern Cooperative Oncology Group Study 5194. Cancer. 2011; 117(6):1156-62.
30. Moran MS, Yang Q, Goyal S, Harris L, Chung G, Haffty BG. Vascular Endothelial Growth Factor (VEGF)
as a Prognostic Marker for Local Relapse in Early-Stage Breast Cancer Patients Treated with Breast Conservation Therapy (BCT). Int J Radiat Oncol Biol Phys. 2011; 81(5):1236-43.
31. Goyal S, Vicini F, Beitsch P, Kuerer H, Keitsch M, Motwani S, Jeruss J, Lyden M, Haffty BG. Ductal
Carcinoma in situ (DCIS) Treated with Breast Conserving Surgery & Accelerated Partial Breast Irradiation (APBI): Comparison of the Mammosite Registry Trial with Intergroup E5194. Cancer. 2011;
32. Taunk NK, Haffty BG, Goyal S. Radiation Recall Five Years after Whole Breast Irradiation for Early Stage
Breast Cancer Secondary to Initiation of Rosuvastatin & Amlodipine. J Clin Oncol. 2011; Jun 6 (E-Pub).
33. Yue NJ, Goyal S, Zhou JH, Khan AJ, Haffty BG. Intra-fractional Target Motions and Uncertainties of
Various Treatment Setup Reference Systems in Accelerated Partial Breast Irradiation. Int J Radiat
Oncol Biol Phys. 2011;79(5):1549-56.
34. Goyal S, Osusky K, Gabel M, Yue NJ, Narra V. A Novel Method of Island Blocking in Whole Abdominal
Radiotherapy using a Modified Electronic Tissue Compensation Technique. Med Dosim. 2010;
35. Haffty BG, Goyal S, Green C, et al. Evaluation Of Single Nucleotide Polymorphisms (SNP) In The P53
Binding Protein Gene (TP53BP1) In Breast Cancer Patients Treated With Breast Conserving Surgery And Whole Breast Irradiation (BCS+RT). Int J Radiat Oncol Biol Phys. 2010 Jun 18. (Epub).
36. Shaikh T, Chen T, Khan AJ, Yue NJ, Kearney T, Cohler A, Haffty BG, Goyal S. Improvement in Inter-
Observer Accuracy in Delineation of the Lumpectomy Cavity Using Fiducial Markers. Int J Radiat Oncol
Biol Phys. 2010; 78(4):1127-34.
37. Haffty BG & Goyal S. Molecular Subtyping of Breast Cancer: Implications for Radiation Therapy. Int J
Radiat Oncol Biol Phys. 2010; 77(5):1293-1295.
38. Rao M, Khan AJ, Moran MS, Hirshfield KM, Ganesan S, Haffty BG, Goyal S. Clinicopathologic
Presentation of Asian-Indian American (AIA) Women with Stage 0, I & II Breast Cancer. J Immigr Minor
Health. 2011;13(1):42-8.
39. Patel A, Goyal S, Wu H, Schiff D, Moran MS, Haffty BG. Mediator of DNA Damage Checkpoint Protein 1
(MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat. 2010; May 15
40. Goyal S, Rao M, Khan AJ, Huzzy L, Mcdonald C, Haffty BG. Evaluation of Acute Toxicity in Patients
Treated With Concurrent Bevacizumab & Radiotherapy. Int J Radiat Oncol Biol Phys. 2011; 79(2):408-
41. Zhou J, Kim S, Jabbour SK, Goyal S, Haffty BG, et al. A Deformable Model-based 3D Registration
Algorithm for Prostate Radiotherapy. Med Phys. 2010; 37(3): 1298-308.
42. Taunk N, Goyal S, Yang Q, Moran MS, Parikh RR, Haffty BG. Prognostic significance of IGF-1R
expression in patients treated with breast conserving surgery and radiation therapy. Radiother Oncol.
43. Chen T, Kim S, Goyal S, Jabbour SK, Zhou J, Rajagopal G, Haffty BG, Yue NJ. Object-Constrained
Meshless Deformable Algorithm for High Speed 3D Non-rigid Registration between CT and CBCT. Med
Phys. 2010; 37(1): 197-210.
44. Goyal S, Parikh RR, Green C, Schiff D, Yang Q, Moran MS, Haffty BG. Clinicopathologic significance of
ERCC-1 expression in patients treated with breast conserving surgery and radiation therapy. Int J
Radiat Oncol Biol Phys. 2010;76(3):679-684.
45. Goyal S, Khan AJ, Vicini F, Beitsch P, Lyden M, Keitsch M, Haffty BG. Factors Associated with Optimal
Cosmetic Results in Patients Treated With Accelerated Partial Breast Irradiation (APBI) by the American Society of Breast Surgeons (ASBS) MammoSite® Breast Brachytherapy Registry Trial. Ann
Surg Oncol. 2009; 16(9):2450-8.
46. Haffty BG, Choi DH, Goyal S, et al. Breast Cancer in Young Women: Incidence of BRCA 1/2 Mutations
Across Racial Groups. Ann Oncol. 2009; 20(10): 1653-9.
47. Goyal S, Cohler A, Camporeale J, Narra V, Yue NJ.
Radiat Med. 2008; 26(10): 573-581.
48. Yue NJ, Kim S, Lewis B, Jabbour S, Narra V, Goyal S, Haffty BG.
Med Phys. 2008; 35(10): 4375-4385.
49. Goyal S, Yue NJ, Millevoi R, Kagan E, Haffty BG, Narra V. Improvement in Dose Homogeniety with
Electronic Tissue Compensation Over IMRT and Conventional RT In Whole Brain Radiotherapy. Radiother Oncol. 2008 Aug; 88(2):196-201.
50. Goyal S, Kearney T, Haffty BG.
Oncology. 21 (2007): 449-461.
51. Goyal S, Prasad D, Harrell FE, Matsumoto J, Rich T, Steiner L
J Neurosurg.103 (2005): 218-223.
52. Chevalier RL, Goyal S, Kim A, Landau D, LeRoith D. Renal tubulointerstitial injury from ureteral
obstruction in the neonatal rat is attenuated by IGF-1. Kidney Int. 57 (2000): 882-90.
53. Chevalier RL, Goyal S, Thornhill BA. EGF improves recovery following relief of unilateral ureteral
obstruction in the neonatal rat. J Urol. 162 (1999): 1532-6.
54. Chevalier RL, Goyal S, Wolstenholme JT, Thornhill BA.
Kidney Int. 54 (1998): 38-47.
1. Goyal S, Haffty BG, Buccholz T, Perez C. Early Stage Breast Cancer. Principles & Practice of Radiation
2. Jardines L, Goyal S, Fisher P, Weitzel J, Royce, M. Breast Cancer Overview. Cancer Management: A
Multidisciplinary Approach. 12th edition. CMPMedica: New York (2009-2011). 3. Jardines L, Goyal S, Royce M. Stages 0 & I Breast Cancer. Cancer Management: A Multidisciplinary
Approach. 12th edition. CMPMedica: New York (2009-2011). 4. Jardines L, Goyal S, Royce M. Stage II Breast Cancer. Cancer Management: A Multidisciplinary
Approach. 12th edition. CMPMedica: New York (2009-2011). 5. Jardines L, Goyal S, Royce M, Jaiyesimi I. Stages III & IV Breast Cancer. Cancer Management: A
Multidisciplinary Approach. 12th edition. CMPMedica: New York (2009-2011). 6. Goyal S, Khan AJ, Haffty BG.in Radiotherapy for Breast Cancer. Emerging Cancer
Therapeutics. Demos Medical: New York, NY (2010). 7. Goyal S & Zannis V. Accelerated Partial Breast Irradiation. Kuerer’s Breast Surgical Oncology. Kuerer
H (ed), 1st Edition. McGraw-Hill: New York, NY (2010). 8. Goyal S & Jabbour S. Gastric Cancer. Handbook of Radiation Oncology. Haffty BG, Wilson LD (eds), 1st
Edition. Jones and Bartlett: Boston, MA (2008). 1. Taunk NK, Kim S, Abramson D, Goyal S. Bilateral Uveal (Choroid) Metastases from Prostate Cancer.
Submitted to the Case Rep Oncol.
2. Danish H & Goyal S. Book Review: Breast Cancer Diagnosis & Treatment. Int J Radiat Oncol Biol Phys.
3. Goyal S & Haffty BG. Breast Cancer Regional Radiation Fields for Supraclavicular and Axillary Lymph
Node Treatment: Is a Posterior Axillary Boost Field Technique Optimal: Wang X, Yue TK, Salehpour M, et al. International Journal of Radiation Oncology*Biology*Physics 74: 86-91, 2009. Breast Diseases: A Year Book Quarterly. 2010 Jan-Mar; 20(4):446-447. 4. Goyal S & Haffty BG. Responses to Intervals Longer Than 20 Weeks From Breast-Conserving Surgery to
Radiation Therapy Are Associated With Inferior Outcome for Women With Early-Stage Breast Cancer Who Are Not Receiving Chemotherapy: Olivotto IA, Lesperance MI, Truong PT, et al. Journal of Clinical Oncology 27: 16-23, 2009. Breast Diseases: A Year Book Quarterly. 2009 Oct-Dec; 20(3):324- 5. Goyal S & Haffty BG. Responses to concurrent radiotherapy and hormone-therapy and outcome for
large breast cancers in post-menopausal women: Bollet MA, Kirova YM, Antoni G, et al (Institut Curie, Paris) Radiother Oncol 85:336-345, 2007. Breast Diseases: A Year Book Quarterly. 2008: 19(3), 257- 1. Poster Presentation. Three-Year Outcomes of a Once Daily Fractionation Scheme for Accelerated
Partial Breast Irradiation (APBI) Using 3-D Conformal Radiotherapy (3D-CRT). American Society of
Therapeutic Radiation Oncology (ASTRO), Atlanta, Ga, 2013. 2. Platform Presentation. Proton Therapy for a Comprehensive Cancer Center. PTCOG. Essen, Germany,
3. Platform Presentation. Current Efforts in Accelerated Partial Breast Irradiation (APBI). Radiological
Society of North America. Chicago, IL, 2012. 4. Platform Presentation. Current Efforts in Hypofractionat at CINJ & RWJMS – Past, Present & Future.
Radiological Society of North America. Chicago, IL, 2012. 5. Poster Presentation. Optimal PTV Margin in Patients with Fiducial Markers Treated with Accelerated
Partial Breast Irradiation (APBI) using 3D-CRT: Final Results of CINJ 040801. American Society of Therapeutic Radiation Oncology (ASTRO), Miami, FL 2011 6. Platform Presentation. Appropriateness Criteria as Substrate for Practice Quality Improvement.
American College of Radiology. Washington DC, 2010. 7. Platform Presentation. Ductal Carcinoma in situ (DCIS) Treated with Wide Excision with >1cm Margins
& Accelerated Partial Breast Irradiation (APBI). American Radium Society. Cancun, 2010 8. Poster Presentation. Development of a Web-Based Radiation Oncology Quality Improvement
Initiation (ROQII) using the ACR Appropriateness Criteria®: Clinically Localized Prostate Cancer Pre- Treatment Screening and Treatment Planning. American Radium Society. Cancun, 2010. 9. Poster Presentation. Development of a Web-Based Radiation Oncology Quality Improvement
Initiation (ROQII) using the ACR Appropriateness Criteria®: Hodgkins Lymphoma Staging. American 10. Poster Discussion. Low Risk Ductal Carcinoma in situ (DCIS) Treated with Breast Conserving Surgery &
Accelerated Partial Breast Irradiation (APBI): Comparison of the Mammosite Registry Trial with Intergroup E5194. San Antonio Breast Cancer Symposium. San Antonio, TX, 2009. 11. Poster Presentation. Optimal Time for Initiation of Accelerated Partial Breast Irradiation (APBI) Using
3-D Conformal Radiotherapy (3D-CRT) – Preliminary Analysis of CINJ 040801. American Society of Therapeutic Radiation Oncology (ASTRO), Chicago, IL, 2009. 12. Poster Presentation. A Free Form Deformation-based 3D Registration Algorithm for Image Guided
Breast Radiotherapy. American Society of Therapeutic Radiation Oncology (ASTRO), Chicago, IL, 2009. 13. Platform presentation. Clinicopathologic significance of ERCC-1 expression in patients treated with
breast conserving surgery and radiation therapy. American Radium Society. Vancouver, 2009. 14. Poster presentation. Evaluation of Acute Toxicity in Patients Treated With Concurrent Bevacizumab &
Radiotherapy. American Radium Society. Vancouver, 2009. 15. Poster presentation. A Novel Method of Island Blocking in Whole Abdominal Radiotherapy using a
Modified Electronic Tissue Compensation Technique. American Radium Society. Vancouver, 2009. 16. Platform presentation. Factors Associated with Optimal Cosmetic Results in Patients Treated With
Accelerated Partial Breast Irradiation (APBI) by the American Society of Breast Surgeons (ASBS) MammoSite® Breast Brachytherapy Registry Trial. Society of Surgical Oncology. Phoenix, AZ, 2009. 17. Platform presentation. A Historical Overview of the Radiotherapy in Breast Cancer. Presented with
Eli Glatstein, MD. American Society of Clinical Oncology. Chicago, IL, 2008. 18. Poster presentation. Improvement in Dose Homogeniety with Electronic Tissue Compensation Over
IMRT and Conventional RT In Whole Brain Radiotherapy. 2008 Annual Retreat on Cancer Research in 19. Poster presentation. Dynamic Multileaf Collimation (dMLC) with Fluence Modulation for Whole Brain
Radiotherapy. American Society of Therapeutic Radiation Oncology (ASTRO), Los Angeles, CA, 2007. 20. Platform presentation. A Historical Overview of the Treatment of Prostate Cancer. Presented with
Anthony D’Amico, MD & Svetlana Jezdic, MD. American Society of Clinical Oncology. Chicago, IL, 21. Platform presentation. Gamma knife surgery for the treatment of intracranial metastases from breast
cancer. Doctoral Student Research Forum. Department of Health Evaluation Sciences, University of 22. Poster presentation. Obstructive nephropathy in the neonatal rat is attenuated by insulin-like growth
factor-1 (IGF-1). Children’s Medical Center 11th Annual Research Day, Charlottesville, VA, 1999. 23. Poster presentation. Epidermal growth factor (EGF) improves recovery after release of unilateral
ureteral obstruction (UUO) in the neonatal rat. American Society of Nephrology, Philadelphia, PA, 24. Poster presentation. Obstructive nephropathy in the neonatal rat is attenuated by insulin-like growth
factor-1 (IGF-1). American Society of Nephrology, Philadelphia, PA, 1998. 25. Platform presentation. Sequelae of obstructive nephropathy in the neonate are attenuated by
exogenous epidermal growth factor (EGF). Pediatric Academic Socieity, Washington, DC, 1997. 26. Platform presentation. Sequelae of obstructive nephropathy in the neonate are attenuated by
exogenous epidermal growth factor (EGF). Children’s Medical Center 9th Annual Research Day,

Source: http://41337c20.cst.lightpath.net/physicians/cv/Sharad-Goyal-MD-11113989.pdf